An Option for Migraine Prevention?

Although not yet approved for migraine, candesartan is promising in a placebo-controlled comparison trial.

Source: Medscape Pharmacists Podcast - June 2, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts